Stay updated with breaking news from John Menditto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Caladrius Biosciences, Inc. , a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or reverse disease, provides a business update and... | March 22, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference ... Caladrius Biosciences, Inc.February 18, 2021 GMT BASKING RIDGE, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that the Company will report its financial results for the three and twelve month...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Caladrius Biosciences Closes $25.0 Million Private Placement Caladrius Biosciences, Inc.January 25, 2021 GMT BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that it has closed on its previously announced sale of an aggregate of 12,500,000 shares of its common stock and warra...